Moreover, analysis of gene expression across pathological stages showed consistent upregulation of CDH1, CDH2, and CDH3 in advanced tumor stages, emphasizing the potential role of cadherin genes in NSCLC progression (Figs. 2E, 2F). The gene discussed is CDH3; the disease is non-small cell lung carcinoma.